CRISPR Therapeutics AG

CRSP

$129.61

+139.47% (1 year change)

Avg closing price

Price range

Market Cap

$8.94 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

Revenue

$148 Thousand

Total revenue in the last quarter.

Net Income

-$92.4 Million

Net income is all revenues minus all expenses including taxes and interest in the last quarter.

Earnings per Share

-$5.29

Earnings per share is the amount of net income that is attributed to each single share outstanding.

Dividends per Share

$0.00 (0.0%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Price-Earnings Ratio

-25.63x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

EBIT

$-92.4 Million

Earnings before interest expenses and taxes in the last quarter.

Employees

0

The number of full time employees.

Revenue & Earnings

Balance Sheet

News

Investing in CRISPR Therapeutics (NASDAQ: CRSP)

Investing in CRISPR Therapeutics (NASDAQ: CRSP)

CRISPR Therapeutics (NASDAQ: CRSP) is a biotechnology company that is developing therapeutics using a new and innovative methodology. CRISPR Therapeutics is named after a genetic editing technique ...

Securities Securities, 2 months ago
CRISPR Therapeutics (NASDAQ:CRSP) Releases Quarterly Earnings Results

CRISPR Therapeutics (NASDAQ:CRSP) Releases Quarterly Earnings Results

CRISPR Therapeutics (NASDAQ:CRSP) posted its quarterly earnings results on Monday. The company reported ($1.50) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($1.27) by ($...

Transcript Daily Transcript Daily, 2 months ago
Meridian Bioscience, CRISPR Therapeutics, Tilray and Uber highlighted as Zacks Bull and Bear of the Day

Meridian Bioscience, CRISPR Therapeutics, Tilray and Uber highlighted as Zacks Bull and Bear of the Day

Meridian Bioscience, CRISPR Therapeutics, Tilray and Uber highlighted as Zacks Bull and Bear of the Day

Yahoo Finance UK Yahoo Finance UK, 2 months ago